Labcorp Holdings Inc
(FRA:N6B)
€
198
-4 (-1.98%)
Market Cap: 16.72 Bil
Enterprise Value: 21.84 Bil
PE Ratio: 42.25
PB Ratio: 2.33
GF Score: 81/100 Laboratory Corporation of America Holdings at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022 / 09:25PM GMT
Release Date Price:
€199.89
(+1.76%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Hi, everyone. Thanks for joining us for the next presentation. We're very happy to have Laboratory Corporation of America as our next presenter, Adam Schechter, Chairman and CEO; and Glenn Eisenberg, EVP and CFO.
I think this is the day of the executives with injuries. Every executive that's coming up here has got some health repair issue. So that may be good for the system there, I guess. But anyway, we really appreciate you guys participating again in our conference.
Questions & Answers
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
What I would love is maybe just talk about since we're 11 months into the year, what have been some of the wins for Laboratory Corporation, Labcorp, and maybe some areas of challenge, if you want to highlight that.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot